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Abstract
In the vertebrate nervous system, myelination of axons for rapid impulse propagation
requires the synthesis of large amounts of lipids and proteins by oligodendrocytes and
Schwann cells. Myelin membranes are thought to be cell-autonomously assembled by
these axon-associated glial cells. Here, we report the surprising finding that in normal brain
development, a substantial fraction of the lipids incorporated into central nervous system
(CNS) myelin are contributed by astrocytes. The oligodendrocyte-specific inactivation of
sterol regulatory element-binding protein (SREBP) cleavage-activating protein (SCAP),
an essential coactivator of the transcription factor SREBP and thus of lipid biosynthesis,
resulted in significantly retarded CNS myelination; however, myelin appeared normal at 3
months of age. Importantly, embryonic deletion of the same gene in astrocytes, or in astrocytes and oligodendrocytes, caused a persistent hypomyelination, as did deletion from
astrocytes during postnatal development. Moreover, when astroglial lipid synthesis was
inhibited, oligodendrocytes began incorporating circulating lipids into myelin membranes.
Indeed, a lipid-enriched diet was sufficient to rescue hypomyelination in these conditional
mouse mutants. We conclude that lipid synthesis by oligodendrocytes is heavily supplemented by astrocytes in vivo and that horizontal lipid flux is a major feature of normal brain
development and myelination.
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Author summary

Abbreviations: bHLH-Zip, basic helix–loop–helix
leucine zipper; CC, corpus callosum; CNS, central
nervous system; CV, conduction velocity; DTI,
diffusion tensor imaging; EM, electron microscopy;
FASN, fatty acid synthase; GFAP, glial fibrillary
acidic protein; GSL, glycosphingolipid; HFD, highfat diet; MAG, myelin-associated glycoprotein;
MBP, myelin basic protein; MUFA,
monounsaturated fatty acids; MRI, magnetic
resonance imaging; ON, optic nerve; OPC,
oligodendrocyte precursor cell; PC, phosphatidyl
choline; PE, phosphatidyl ethanolamine; PI,
phosphatidyl inositol; PLP, myelin proteolipid
protein; PNS, peripheral nervous system; PS,
phosphatidyl serine; PUFA, polyunsaturated fatty
acids; SC, Schwann cells; SCAP, SREBP cleavageactivating protein; SD, standard diet; SFA, saturated
fatty acids; SM, sphingomyelin; SQS, squalene
synthase; SREBP, sterol regulatory elementbinding protein; tdT, td-Tomato; WT, wild-type.

The myelin membrane is a highly specialized plasma membrane that enwraps axons, acts
as an insulator, and is thus important for fast conduction of action potentials. It is thereby
critical for proper functioning of the nervous system. Myelin in the central nervous system
is synthesized by oligodendrocytes. Because myelin has a high lipid content, it is vulnerable to lipid metabolism disorders. It is unknown whether extracellular lipids also contribute to myelination by oligodendrocytes under healthy conditions, and if they do, what the
origin of these lipids would be.
Here, we show that formation of myelin membrane in mice does not only need lipid
synthesis by oligodendrocytes, but also requires extracellular lipids provided by astrocytes.
Indeed, when lipid synthesis was inactivated in either oligodendrocytes or astrocytes,
myelin membrane synthesis was reduced. However, when lipid synthesis was inactivated
in both cell types, myelin membrane synthesis was virtually absent. Furthermore, when
lipid synthesis was inactivated in astrocytes, oligodendrocytes bypassed this deficiency by
using dietary lipids for myelin membrane synthesis. Furthermore, a high-fat diet could
promote myelin synthesis. We conclude that extracellular lipids, either provided by astrocytes or in the diet, contribute to myelination by oligodendrocytes during normal brain
development.

Introduction
Myelin membrane integrity is critical for proper functioning of the nervous system. Myelin
acts as an insulator by increasing the electrical resistance across the cell membrane and by
decreasing membrane capacitance, thereby ensuring the fast conduction of action potentials
between nodes of Ranvier over long distances[1,2]. Myelin is a specialized membrane organelle
synthesized by Schwann cells (SC) in the peripheral nervous system (PNS) and by oligodendrocytes in the central nervous system (CNS) [3]. A prominent biochemical characteristic of
myelin is its high lipid-to-protein ratio. Lipids account for at least 70% of the dry weight of the
myelin membrane[4], which is twice that of other plasma membranes[5]. The high lipid content of the myelin membrane makes it vulnerable for lipid metabolism disorders[5] and makes
lipid availability rate-limiting for myelination. Accordingly, genetic impairment of endogenous lipid synthesis in SC interferes with the acute phase of PNS myelination[6]. Interestingly,
uptake of extracellular lipids by these cells partially rescues myelination over time[6]. Similarly,
mice carrying an oligodendrocyte-specific deletion of squalene synthase (SQS), an enzyme
required for cholesterol synthesis, have CNS hypomyelination, but this marks a delay, and
myelination becomes nearly normal at 3 months[7]. It is unknown whether extracellular lipids
also contribute to myelination by oligodendrocytes in the CNS under healthy conditions, and,
if they do, what the origin of these lipids would be.
The CNS is classically viewed as being largely autonomous in lipid metabolism since it is
shielded from lipids in the circulation by the blood–brain barrier[8,9]. One cellular source
of lipid synthesis and secretion is the astrocyte[10–17], and in vitro studies have shown that
astrocytes are able to promote myelination in neuron-oligodendrocyte co-cultures[18–20].
Recently, we found that cholesterol and fatty acid synthesis in astrocytes relies on sterol regulatory element binding proteins (SREBPs)[11]. SREBPs, consisting of SREBP-1a, SREBP1c, and SREBP-2, belong to the family of basic helix–loop–helix leucine zipper (bHLH-Zip)
transcription factors that govern the transcriptional activation of genes involved in fatty acid
and cholesterol metabolism[21] and are posttranslationally activated by the sterol sensor
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SREBP cleavage-activating protein (SCAP)[22]. The recent demonstration that SREBPs are
regulated by mTORC1, a signaling complex important for both PNS and CNS myelination
[23,24], is consistent with an important role of the SCAP–SREBP pathway in both SC [6] and
oligodendrocytes.
Here, we used glial cell-restricted inactivation of SCAP-SREBP–mediated lipid biogenesis
to determine the individual role of oligodendrocyte and astrocyte lipid metabolism in CNS
myelination. We found that myelin membrane formation not only builds on oligodendrocyte
endogenous lipid synthesis, as generally thought, but also critically depends on extracellular
lipids provided by astrocytes.

Results
SCAP deletion in oligodendrocytes interferes with the acute phase of
myelination
To inactivate lipid biosynthesis in oligodendrocytes, we crossed SCAP-floxed mice[22] with
mice expressing Cre recombinase specifically in oligodendrocytes and SCs (CNP-Cre)[25].
CNP-cre/SCAPloxP/loxP mutant mice, referred to as CNP-SCAP mice in the following, were
born at normal Mendelian ratios and were indistinguishable from controls at birth. SCAP is
required for the processing of SREBPs into active transcription factors[22]. Accordingly, in
CNP-SCAP animals, we detected reduced levels of cleaved (mature) SREBP2 proteins at P20
in spinal cord (where oligodendrocytes form a large cell population) (Fig 1A and 1B). In addition, SREBP2 precursor levels were strongly reduced (Fig 1A and 1B), which is consistent with
previous observations that SCAP also regulates the expression of the SREBP genes[6,22]. The
residual detectable SREBP2 protein in CNP-SCAP mice likely comes from other cell types,
predominantly astrocytes, which are active in lipid metabolism[11,17,25]. As such, white matter expression of fatty acid synthase (FASN), a SREBP target gene [21], was observed in oligodendrocytes and strongly reduced in CNP-SCAP mutants (Fig 1C and 1D). Low FASN
expression was observed in astrocytes and was unaffected in CNP-SCAP mutants (Fig 1C and
1D). No expression of FASN was observed in neurons in the cortex or hippocampus (S1 Fig).
CNP-SCAP mice show reduced survival, probably caused by lethal seizures, with the most critical phase around weaning (weeks 2–4) (Fig 1E), and reduced weight gain (Fig 1F). Moreover,
CNP-SCAP mice exhibit tremors and an unsteady gait after postnatal week 2 (Fig 1G), as well
as microcephaly (Fig 1H).
Electron microscopy (EM) demonstrated that CNP-SCAP optic nerves were hypomyelinated at P20 and appeared normal at P120, although still mildly hypomyelinated (Fig 2A). Gratio measurements of myelinated fibers confirmed that hypomyelination of the optic nerve
was severe at P20 and restored to almost normal levels by P120 (Fig 2B). Axon diameter distribution was not significantly affected (Fig 2B). Accordingly, myelin membrane thickness of
CNP-SCAP mice was thinner at P20 and improved at P120 (Fig 2B). The quantification of the
number of Olig2+ cells (P20; Fig 2C) showed that oligodendrocyte-specific ablation of SCAP
had no effect on oligodendrocyte precursor cell (OPC)/oligodendrocyte cell numbers, and
proliferation of oligodendrocyte lineage cells (Ki67+Olig2+ cells) was slightly increased. The
quantification of CC1+Olig2+ mature oligodendrocytes revealed lower numbers in CNP-SCAP
mutants (Fig 2C).
Next, we determined the effect of SCAP deletion on myelin lipid composition. Lipid analysis of purified myelin of CNP-SCAP adult brains (P56) demonstrated no changes in phospholipid classes (Fig 3A) or sterols (Fig 3B). The fatty acid composition of phospholipids in
mutant myelin was significantly shifted from monounsaturated fatty acids towards polyunsaturated fatty acids, which was also visible in a decrease in the ratio of 18:1/18:2 (Fig 3C).
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Fig 1. Conditional inactivation of SREBP cleavage-activating protein (SCAP) in oligodendrocytes reduces
lipogenic gene expression and causes motor control defects and reduced survival. A) Protein levels of
precursor sterol regulatory element-binding protein 2 (SREBP2) and mature (processed) SREBP2 were determined
by immunoblotting of total extracts of the spinal cord of wild-type (WT) and CNP-SCAP animals at P20 (n = 3).
Detection of mature and precursor SREBP2 was performed using different exposure times, and representative
pictures are shown. Detection of beta-actin and on-blot protein stain was used to control for equal loading. B)
Histogram shows quantification of precursor and mature SREBP2 protein levels after correction for equal loading
(using on-blot stain) and subsequent normalization to WT levels in which the WT levels were set to 1, and the
ratio between mature/precursor SREBP in which the ratio for WT was set to 1. All data are presented as mean
levels ± SEM (t test: *p < 0.05, #p = 0.059). C) Expression of fatty acid synthase (FASN, green) in oligodendrocytes
(Olig2, blue) and astrocytes (glial fibrillary acidic protein [GFAP], red) of WT or CNP-SCAP mutant mice at P20.
Asterisks denote oligodendrocytes with FASN expression; arrowheads denote astrocytes with FASN expression
(scale bar, 25 μm). D) Number of FASN-positive oligodendrocytes (Olig2+FASN+) and FASN-positive astrocytes
(GFAP+FASN+) in WT and CNP-SCAP mice (n = 3). The values are provided as the percentage of the total number
of oligodendrocytes (Olig2+ cells) or astrocytes (GFAP+ cells). Data are presented as mean ± SEM. **p < 0.01
using t test. E) Kaplan-Meier survival plot showing a strongly reduced life span of CNP-SCAP mice compared to
age-matched WT mice. F) Body weight development of WT and CNP-SCAP mice over a 3-month period. Shown
are the mean and SEM. G) At a grid test, CNP-SCAP mice showed limb ataxia, causing frequent slips of the hind
limbs (red arrow) or front limbs. Mutant mice showed an abnormal reaction when tail lifted; they attempted to clasp
their hind limbs and clench the toes of their rear feet. H) CNP-SCAP brains compared to control littermates at P28.
The numeric data underlying Fig 1B, D, E and F can be found in S1 Data.
https://doi.org/10.1371/journal.pbio.1002605.g001

CNP-SCAP mutant myelin contained more polyunsaturated fatty acids and had higher levels
of the essential fatty acid C18:2, which is consistent with an increased uptake of fatty acids
from external sources[5,6].
Taken together, compromised lipid metabolism in oligodendrocytes leads to a severe developmental delay in myelin synthesis, accompanied by a compensatory increase in uptake of
fatty acids from external sources and a largely improved phenotype in adult mice. This raises
the question whether other cell types, in particular astrocytes, represent suppliers of lipids for
lipogenesis-deficient oligodendrocytes.

CNS hypomyelination in astrocyte SCAP mutants
To determine the role of astrocyte-derived extracellular lipids in myelination, we analyzed glial
fibrillary acidic protein (GFAP)-SCAP mice, in which SCAP was deleted from the majority of
astrocytes by Cre recombination [11]. Accordingly, the number of astrocytes with FASN
expression was strongly reduced in GFAP-SCAP mutants, whereas the number of FASNexpressing oligodendrocytes was not changed (Fig 4A). We previously noticed microcephaly
in GFAP-SCAP mice [10]. Structural magnetic resonance imaging (MRI) revealed a large
decrease in white matter volume of GFAP-SCAP mutants (to less than 60% of the wild-type
[WT] volume), whereas grey matter volume was only reduced by 10% (Fig 4B, 4C and S2A
Fig). MRI-based 3D reconstructions of GFAP-SCAP mutant brains showed the most pronounced reduction in the corpus callosum (S2B Fig). Using diffusion tensor imaging (DTI) we
found a lower degree of fractional anisotropy for the main tracts in GFAP-SCAP mutant
brains compared to WT (Fig 4D). Reduced fractional anisotropy, a measure for axon fiber
bundle packing [26,27], in GFAP-SCAP mutants likely reflects a reduction in the number of
myelin tracts. In line with this, Sudan Black staining of lipid-rich structures showed smaller
white matter structures, particularly in the corpus callosum and internal capsule (Fig 4E). No
changes in hippocampal or cortical region sizes were observed, in line with previous observations [11]. Taken together, SCAP deletion in astrocytes leads to reduced and less well-structured CNS white matter tracts.
Further analysis revealed a reduced density of corpus callosum myelinated fibers in adult
GFAP-SCAP mutants relative to control animals (Fig 5A) due to the absence of myelin around
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Fig 2. Reduced myelination in the central nervous system (CNS) of CNP-SREBP cleavage-activating protein (SCAP) mutant
mice. A) Electron microscopic analysis of optic nerve myelin in cross-sections of either wild-type (WT) or CNP-SCAP mice at depicted
time points (scale bar, 2 μm). Bar graph shows the percentage of axons that is myelinated. B) Morphometric analysis of axons in optic
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nerves of WT and CNP-SCAP mice, showing g-ratio (axon diameter/myelinated fiber diameter), axonal size distribution (both myelinated
and nonmyelinated axons), and myelin membrane thickness at P20 and P120. At P20, the relation axon diameter (x) and g-ratio (y) was
y = 7E − 05x + 0.7312 for WT and y = 9E − 05x + 0.796 for CNP-SCAP, with coefficients of determination R2 = 0.45013 (WT) and 0.28818
(CNP-SCAP). At P120: y = 8E − 05x + 0.731 (WT); y = 0.0001x + 0.7253 (CNP-SCAP), R2 = 0.2957 (WT) and 0.27524 (CNP-SCAP). C)
Expression of postmitotic marker CC1 (blue) or proliferation marker Ki67 (green) in oligodendrocytes (Olig2, red) of WT or CNP-SCAP
mutant mice in the corpus callosum at P20. The arrow and arrowhead denote examples of oligodendrocytes, respectively, with or without
CC1 expression. The asterisks denote an oligodendrocyte with Ki67 expression (scale bar, 40 μm). The bar graph shows the density of the
total number of oligodendrocytes (Olig2+ cells), immature oligodendrocytes (Olig2+Ki67+ cells), and postmitotic mature oligodendrocytes
(Olig2+CC1+ cells) in WT and CNP-SCAP mice. Data are presented as mean ± SEM. * = p < 0.05 ** = p < 0.01 using t test, n = 3–4. The
numeric data can be found in S1 Data.
https://doi.org/10.1371/journal.pbio.1002605.g002

the small diameter axons (<0.5 μm). Moreover, myelin of the large diameter callosum axons
was thinner, as demonstrated by a higher g-ratio in GFAP-SCAP mutants. No changes in axonal diameter were found (Fig 5B). Analysis of the optic nerves showed that GFAP-SCAP

Fig 3. Myelin from CNP-SREBP cleavage-activating protein (SCAP) brains shows changes in fatty acid
composition. Lipid extracts of purified myelin of wild-type (WT) and CNP-SCAP brains at P56 were analyzed using
liquid chromatography and mass spectrometry. A) Polar membrane lipid concentration and B) sterol concentration
per protein amount in CNP-SCAP compared to WT myelin. GSL, glycosphingolipid; PI, phosphatidyl inositol; PE,
phosphatidyl ethanolamine; PS, phosphatidyl serine; PC, phosphatidyl choline; SM, sphingomyelin. C) Fatty acid
profile of phospholipids from purified myelin with the amount of different fatty acids species as percentage of the
total amount. Fatty acid species are depicted as “y:z,” with “y” giving the length of the fatty acid molecules and “z”
the number of double bonds. Insert: depicted are proportions of saturated fatty acids (SFA), monounsaturated fatty
acids (MUFA), polyunsaturated fatty acids (PUFA), and the ratio of 18:1/18:2. Data are presented as mean
percentage of WT ± SD. t tests: * = p < 0.05; ** = p < 0.01; *** = p < 0.001, n = 5. The numeric data can be found in
S1 Data.
https://doi.org/10.1371/journal.pbio.1002605.g003
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Fig 4. Conditional inactivation of SREBP cleavage-activating protein (SCAP) in astrocytes reduces lipogenic gene
expression and white matter volume. A) Expression of fatty acid synthase (FASN, green) in oligodendrocytes (Olig2, blue) and
astrocytes (glial fibrillary acidic protein [GFAP], red) of wild-type (WT) or GFAP-SCAP mutant mice at P14. Asterisks denote
oligodendrocytes with FASN expression; arrowheads denote astrocytes with FASN expression (scale bar, 25 μm). Bar graph
shows the number of FASN-positive oligodendrocytes (Olig2+FASN+) and FASN-positive astrocytes (GFAP+FASN+) in WT and
GFAP-SCAP mice. The values are provided as the percentage of the total number of oligodendrocytes (Olig2+ cells) or astrocytes
(GFAP+ cells). Data are presented as mean ± SEM. ** = p < 0.01 using t test, n = 3. B) The average T2-weighted magnetic
resonance image (MRI), in coronal slices, shows clear diminished white matter in the GFAP-SCAP mice (B, middle) as compared
to the average WT image (B, left). Deformation-based morphometry analysis revealed regional differences in tissue volumes in
the brains of GFAP-SCAP, mostly in the white matter areas (significant higher volumes in WT shown from red to yellow p < 0.05 to
0.0001, n = 4–5), overlaid on the average WT image (B, right). See S2 Fig for complete scans. C) Volumes of the whole brain and
the white and grey matter of GFAP-SCAP and WT mice, as determined with MRI. Volumes are normalized to WT levels that were
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set to 100%. Data are shown as mean ± SEM (t test ** = p < 0.01, n = 4–5. D) Diffusion tensor imaging (DTI) of the same brains as
in A, showing reduced fractional anisotropy in GFAP-SCAP mutant brains. Arrowheads show examples of the most affected white
matter regions, e.g., corpus callosum, internal capsule, and corticospinal tract. E) Sudan Black staining shows less white matter in
GFAP-SCAP compared to WT animals (8 months). Arrowheads show the most affected regions, i.e., corpus callosum and internal
capsule (scale bar, 200 μm). The numeric data underlying Fig 4A and C can be found in S1 Data.
https://doi.org/10.1371/journal.pbio.1002605.g004

nerves were also hypomyelinated, although the percentage of myelinated axons was not significantly affected (Fig 5C). G-ratio measurements confirmed that hypomyelination of the optic
nerve, particularly for the small diameter axons, was present at P20 and persisted in adults (Fig
5D), whereas no changes in axonal diameter were found.
We previously showed that GFAP-SCAP mice have no changes in neuronal or astrocyte
densities [10]. Quantification of Olig2+ cell numbers (P14; Fig 6A) showed that GFAP-SCAP
mice had no significant changes in the number of OPC/oligodendrocyte cells, CC1+Olig2+
mature oligodendrocytes, nor in proliferating oligodendrocyte lineage cells (Ki67+Olig2+ cells)
(Fig 6A). The levels of myelin proteins, such as myelin basic protein (MBP) and myelin-associated glycoprotein (MAG), were also reduced in GFAP-SCAP mice at P120 (Fig 6B), whereas
smaller reductions in myelin protein levels were found at P14. No changes between WTs and
GFAP-SCAP mutants were found for Olig2 and NeuN (Fig 6B). These data demonstrate that
astrocyte SCAP mutants have lower numbers of fully myelinating oligodendrocytes.
To establish a role of astrocytes during a later stage of myelination, we induced SCAP deletion specifically in astrocytes around the developmental peak of myelination (P20) [28]. To
accomplish this, Glast-CreERT2-tdT-SCAP mice were injected with tamoxifen at P15–P17,
which prevents potential neural progenitor perinatal and early postnatal targeting [29,30].
Glast-CreERT2-tdT mice (P56) had td-Tomato (tdT) reporter gene expression in the corpus
callosum in the large majority of GFAP+ astrocytes, while virtually no expression was found in
Olig2+ oligodendrocytes or axons (Fig 7A). Accordingly, FASN expression was strongly
reduced in astrocytes of Glast-CreERT2-tdT-SCAP adult mice (Fig 7B). EM showed that the
corpus callosum of Glast-CreERT2-tdT-SCAP mutant mice was hypomyelinated at P56 (Fig
7C), without affecting the percentage of myelinated axons (Fig 7D), which predominantly
affected the small caliber fibers (Fig 7E). In contrast, axonal diameter was not affected (Fig 7F).
Taken together, these results demonstrate that compromised astrocyte lipid metabolism,
also when induced during postnatal development, limits myelin membrane synthesis causing
persistent CNS hypomyelination.

Oligodendrocytes show compensatory incorporation of dietary lipids in
the myelin membrane when astrocyte lipid synthesis is compromised
Lipid analysis of purified myelin from GFAP-SCAP brains (P42) revealed no changes in phospholipid classes (Fig 8A) or cholesterol (Fig 8B), which was similar to our observations in
CNP-SCAP mutant mice (cf. Fig 3). Interestingly, however, GFAP-SCAP myelin membranes
contained more sitosterol and campesterol (Fig 8B), albeit at trace levels compared to cholesterol (in mutant myelin: 0.66 and 2.64 pmol/ug protein of resp. sitosterol and campesterol versus 2.07 nmol/ug protein cholesterol). Since sitosterol and campesterol are 2 plant sterols that
can only be derived from diet, this finding suggested that GFAP-SCAP mutants unexpectedly
incorporated plasma-derived sterols into myelin. The fatty acid composition of phospholipids
was significantly shifted from monounsaturated fatty acids towards polyunsaturated fatty
acids, and a decrease in the ratio of 18:1/18:2 in mutant myelin was observed (Fig 8C). As
observed in CNP-SCAP mice (cf. Fig 3), GFAP-SCAP mutant myelin also contained more
polyunsaturated fatty acids and had higher levels of the essential fatty acid C18:2, which is consistent with an increased uptake of fatty acids from external sources[5,6]. In this manner,
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Fig 5. Persistent hypomyelination in glial fibrillary acidic protein (GFAP)- SREBP cleavage-activating protein
(SCAP) mutant brains. A) Electron microscopy (EM) analysis of corpus callosum myelination in cross-sections of
either wild-type (WT) or GFAP-SCAP mice at P120. Bar graph shows the percentage of axons that is myelinated. B)
Morphometric analysis of axons on corpus callosum of WT and GFAP-SCAP mice, showing g-ratio (myelinated axons)
and axonal size distribution (both myelinated and non-myelinated axons) at P120. The relation between axon diameter
(x) and g-ratio (y) was y = 9E − 05x + 0.7287 for WT and y = 7E − 05x + 0.8008 for GFAP-SCAP, with coefficients of
determination R2 = 0.25384 (WT) and 0.11285 (GFAP-SCAP). C) EM analysis of optic nerve myelination in crosssections of either WT or GFAP-SCAP mice at depicted time points. Bar graph shows the percentage of axons that is
myelinated. D) Morphometric analysis of axons on optic nerves of WT and GFAP-SCAP mice, showing g-ratio
(myelinated axons), axonal size distribution (both myelinated and nonmyelinated axons), and myelin membrane
thickness at P20 and P120. At P20, the relation between axon diameter (x) and g-ratio (y) was y = 8E − 05x + 0.7262 for
WT and y = 5E − 05x + 0.8003 for GFAP-SCAP, with coefficients of determination R2 = 0.31108 (WT) and 0.11441
(GFAP-SCAP). At P120: y = 9E − 05x + 0.7079 (WT); y = 3E − 05x + 0.825 (GFAP-SCAP), R2 = 0.3288 (WT) and R2 =
0.06062 (GFAP-SCAP). Scale bars, 2 μm. t test # p = 0.079, * p < 0.05, ** p < 0.01, n = 3. The numeric data can be
found in S1 Data.
https://doi.org/10.1371/journal.pbio.1002605.g005

compromised lipid metabolism in astrocytes leads to a reduction in myelin membrane synthesis, as well as a compensatory increase in oligodendrocyte uptake of sterols and fatty acids
from the circulation.

Fig 6. Reduced myelin proteins levels in glial fibrillary acidic protein (GFAP)- SREBP cleavage-activating protein (SCAP) mice. A)
Expression of postmitotic marker CC1 (blue) or proliferation marker Ki67 (green) in oligodendrocytes (Olig2, red) of wild type (WT) or GFAP-SCAP
mutant mice in the corpus callosum at P14. The arrow and arrowhead denotes examples of oligodendrocytes with or without CC1 expression,
respectively. The asterisks denote an oligodendrocyte with Ki67 expression (scale bar, 40 μm). The bar graph shows the density of the total number
of oligodendrocytes (Olig2+ cells), immature oligodendrocytes (Olig2+Ki67+ cells) and postmitotic mature oligodendrocytes (Olig2+CC1+ cells) in WT
and GFAP-SCAP mice. B) Protein levels of Olig2 (oligodendrocyte marker), myelin basic protein (MBP) and myelin-associated glycoprotein (MAG),
NeuN (neuronal marker), and β-actin (loading control) were determined by immunoblotting of total brain extracts of WT and GFAP-SCAP mutant
animals at P14 and P120. The bar graph shows quantification of protein levels that were first corrected for equal loading using coomassie staining,
subsequently normalized to WT levels at P14 and then set to 100%. Data are presented as mean ± SEM. * = p < 0.05 ** = p < 0.01 using t test,
n = 3. The numeric data can be found in S1 Data.
https://doi.org/10.1371/journal.pbio.1002605.g006
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Fig 7. Postnatal tamoxifen-induced inactivation of SREBP cleavage-activating protein (SCAP) in astrocytes
interferes with full myelin membrane synthesis. A) Expression analysis of recombination-reporter protein td-Tomato (tdT,
red) in astrocytes (glial fibrillary acidic protein [GFAP], green), oligodendrocytes (Olig2, green), or neurons (NeuN, green) in
the corpus callosum of Glast-CreERT2-tdT-SCAP animals (P56) treated with tamoxifen at P15–P17. Arrowheads denote cells
that show coexpression of tdT with cell-type specific markers (scale bar, 25 μm). B) Expression of fatty acid synthase (FASN,
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in green) in astrocytes in tamoxifen-treated control (ctrl, with GFAP in red) or SCAP mutant mice (Mut). Astrocytes are visible
by GFAP staining (red, for ctrl mice) or tdT expression (red, Mut). Arrowheads denote FASN+ astrocytes, asterisks denote
FASN+ cells that are negative for GFAP or tdT (scale bar, 25 μm). Bar graph shows the number of FASN-positive astrocytes in
WT (GFAP+FASN+ cells) and GFAP-SCAP mice (tdT+FASN+ cells) or FASN-positive non-astrocyte cells (GFAP-FASN+ or
tdT-FASN+ cells). The values are provided as a percentage of the total number of cells expressing GFAP, tdT, or FASN. Data
are presented as mean ± SEM. *** = p < 0.001 using t test, n = 3. C) Electron microscopy (EM) analysis of corpus callosum
myelination in cross-sections of either tamoxifen-treated control (ctrl) or SCAP mutant mice (Mut) at P56. The relation between
axon diameter (x) and g-ratio (y) was y = 0.1308x + 0.6872 for Ctrl and y = 0.1022x + 0.7408 for Mut, with coefficients of
determination R2 = 0.32986 (Ctrl) and R2 = 0.29418 (Mut). D) Bar graph shows the percentage of axons that are myelinated. E)
Morphometric analysis of axons on optic nerves of Ctrl and SCAP mutant mice showing g-ratio per class of axonal diameter for
myelinated axons, and F) axonal size distribution for both myelinated and nonmyelinated axons. t test * = p < 0.05. ** =
p < 0.01, n = 3. The numeric data underlying Fig 7B and C can be found in S1 Data.
https://doi.org/10.1371/journal.pbio.1002605.g007

Fig 8. Myelin from glial fibrillary acidic protein (GFAP)-SREBP cleavage-activating protein (SCAP) brains
shows increased accumulation of dietary lipids. Lipid extracts of purified myelin of GFAP-SCAP brains (P42) were
analyzed using liquid chromatography and mass spectrometry. A) Polar membrane lipid concentration and (B) sterol
concentration per protein amount in GFAP-SCAP compared to wild-type (WT) myelin. GSL, glycosphingolipid; PI,
phosphatidyl inositol; PE, phosphatidyl ethanolamine; PS, phosphatidyl serine; PC, phosphatidyl choline; SM,
sphingomyelin. C) Fatty acid profile of phospholipids from purified myelin with the amount of different fatty acids
species as the percentage of the total amount. Fatty acid species are depicted as “y:z,” with “y” representing the length
of the fatty acid molecules and “z” representing the number of double bonds. Insert: depicted are proportions of
saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA), and the ratio of
18:1/18:2. Data are presented as the mean percentage of WT ± SD. t tests: * = p < 0.05; ** = p < 0.01; *** =
p < 0.001, n = 4. The numeric data can be found in S1 Data.
https://doi.org/10.1371/journal.pbio.1002605.g008
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Fig 9. Effects of a high-fat diet (HFD) on myelination, myelin protein levels, and white matter conduction velocity. A)
Electron microscopy (EM) analysis of optic nerve (ON) and corpus callosum (CC) myelination in cross-sections of glial fibrillary
acidic protein (GFAP)-SREBP cleavage-activating protein (SCAP) mice (P120) on either a standard diet (SD) or HFD. See Fig 5A
and 5C for representative EM images of wild-type (WT) animals (P120) on SD or HFD. Scale bar, 2 μm. Bar graphs, percentage of
axons that are myelinated (left). Morphometric analysis of myelinated axons showing g-ratio (middle and right). For ON of
GFAP-SCAP mice, the relation between axon diameter (x) and g-ratio (y) was y = 3E − 05x + 0.825 for SD and y = 6E − 05x
+ 0.7687 for HFD, with coefficients of determination R2 = 0.06062 (SD) and R2 = 0.23735 (HFD). For CC of GFAP-SCAP mice, the
relation between axon diameter (x) and g-ratio (y) was y = 7E − 05x + 0.8008 for SD and y = 0.0001x + 0.701 for HFD, with
coefficients of determination R2 = 0.11285 (SD) and R2 = 0.26559 (HFD). t test, ** p < 0.01, * p < 0.05, # p = 0.07, n = 3–4. B)
Immunoblot against depicted myelin proteins and coomassie staining of protein levels of total brain extracts of GFAP-SCAP
mutant and WT mice (P120) fed with SD or HFD. Right panel: quantification of immunoblot for depicted myelin proteins for
GFAP-SCAP and WT mice fed with SD or HFD (n = 3). Coomassie staining was used for normalization. Data are presented as
mean ± SEM, in which WT-SD levels were set to 100%. t test * p < 0.05; ** p < 0.01). C) Example of compound action potential
waveforms in the CC for a WT mouse on a standard diet (WT-SD), and a GFAP-SCAP mutant mouse on a standard diet
(GFAP-SCAP-SD) or high fat diet (GFAP-SCAP-HFD). Right panel: individual plots of conduction velocity measurements in the
CC of GFAP-SCAP mutant and WT fed with SD or HFD. Chi-square test, n = 12–17, * p < 0.05, *** < 0.001. The numeric data
can be found in S1 Data.
https://doi.org/10.1371/journal.pbio.1002605.g009

Next, we tested whether hypomyelination in these mice could be rescued by further increasing dietary lipid intake. We previously showed that GFAP-SCAP mice treated from E15
onwards with a high-fat diet (HFD), enriched in cholesterol and fatty acids, improved motor
deficits and survival of the mutant mice [11]. Here we show that HFD treatment rescued hypomyelination, as shown for the optic nerve and the corpus callosum at P120 (Fig 9A), and
increased the levels of myelin proteins, e.g., MAG, myelin proteolipid protein (PLP), CNP,
and MBP in brains of GFAP-SCAP mutants, while GFAP protein levels were not changed (Fig
9B). To determine whether HFD treatment also led to functional recovery of myelin tracts, we
measured action potential conduction velocity (CV) in the corpus callosum. In the majority of
corpus callosum slices from WT animals tested, extracellular stimulation evoked compound
action potentials that showed 2 discrete propagation speeds (0.86 ± 0.03 m/s “fast wave,”
n = 36, and 0.38 ± 0.02 m/s “slow wave,” n = 27; Fig 9C). These were most likely generated by
myelinated axons (fast wave) and nonmyelinated axons (slow wave), respectively. In GFAPSCAP animals, the fast wave was absent in more than 95% of the corpus callosum slices
(p < 0.001, chi-square test), while the slow wave was unaffected (Fig 9C). Thus, SCAP deletion
in astrocytes most likely specifically affected action potential propagation in myelinated axons.
Interestingly, treatment with HFD increased the number of fast responses in GFAP-SCAP animals from 5% (in standard diet) to 50% (p = 0.03), whereas no effect on conduction velocity
was observed in WT animals (0.79 ± 0.05 m/s, n = 19, p > 0.05). Thus, a HFD partially rescues
both myelination and conduction velocity of GFAP-SCAP mutants. Altogether, our results
show that compromised lipid metabolism in astrocytes leads to CNS hypomyelination, which
can be overcome structurally and functionally by a high-fat diet.

Myelination is virtually blocked when lipid synthesis is compromised in
both oligodendrocytes and astrocytes
Our observations imply that CNS myelin membrane synthesis not only requires endogenous oligodendrocyte lipid synthesis but also crucially depends on extracellular lipids provided by astrocytes.
We therefore created CNP-SCAP/GFAP-SCAP animals, in which SCAP was deleted in both oligodendrocytes and astrocytes. CNP-SCAP/GFAP-SCAP mutant mice were born at expected ratios
and could phenotypically not be distinguished from WTs. However, animals soon developed
motor deficits and reduced weight gain more severe than single CNP-SCAP mice, and all mice
died or reached a humane endpoint requiring euthanasia between P15–P21. The corpus callosum
and optic nerves of CNP-SCAP/GFAP-SCAP animals (P20) were practically devoid of myelin (Fig
10A). Oligodendrocytes ensheathed large caliber fibers, but failed to make more than a few
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Fig 10. Virtually no myelin membrane synthesis in CNP-SREBP cleavage-activating protein (SCAP)/glial fibrillary
acidic protein (GFAP)-SCAP brains. A) Electron microscopy (EM) analysis of the corpus callosum (CC) and optic nerve
(ON) in P20-old wild-type (WT) mice or mice carrying a deletion in both astrocytes and oligodendrocytes (CNP-SCAP/
GFAP-SCAP). Bar graphs show the percentage of axons that are myelinated. B) Enlarged view on part of the electron
micrograph of CNP-SCAP/GFAP-SCAP ON in A. C) morphometric analysis of myelinated axons in the ON of WT,
CNP-SCAP, GFAP-SCAP, and CNP-SCAP/GFAP-SCAP mice at p20, showing myelin membrane thickness. n = at least
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3 animals. Membrane thickness for each CNP-SCAP/GFAP-SCAP animal was determined for at least 22 axons that
were wrapped by oligodendrocyte membrane, as depicted in 10B and D. D) Electron microscopic analysis of myelin
membranes in the ON of WT, CNP-SCAP, GFAP-SCAP, and CNP-SCAP/GFAP-SCAP mice. Data are presented as
mean ± SEM. t test * p < 0.05, *** p < 0.001, n  3. Scale bar, (A) 2 μm, (B) 0.75 μm, (C) 0.1 μm. The numeric data
underlying Fig 10A and C can be found in S1 Data.
https://doi.org/10.1371/journal.pbio.1002605.g010

membrane layers (Fig 10B). Accordingly, whereas myelin membranes were thinner in CNP-SCAP
and GFAP-SCAP animals, they were nearly absent in CNP-SCAP/GFAP-SCAP animals (Fig 10C
and 10D). Treatment of dams with HFD did slightly increase the body weight of their CNP-SCAP/
GFAP-SCAP pups. Nevertheless, all animals died or reached a humane endpoint between P15–
P21, and analysis of white matter showed no improvement in hypomyelination (S3 Fig), suggesting
that the resulting developmental defect was too severe to be rescued by dietary lipid supplementation. Taken together, myelin membrane synthesis shows different kinetics when lipid synthesis is
compromised in either oligodendrocytes or astrocytes, whereas it is virtually absent when lipid synthesis is compromised in both cell types.

Discussion
We showed that SCAP is required for the activation of SREBP-mediated lipogenic gene expression in oligodendrocytes and observed that oligodendrocyte SCAP mutant brains are hypomyelinated during the regular peak of myelination and slowly regain close-to-normal levels of
myelin membrane with age. These data are in line with previous observations in CNPcre-SQS
mice, in which cholesterol-deficient oligodendrocytes are able to slowly synthesize myelin
[7,31], although recent observations indicate that targeting of neuronal populations in the cortex cannot be excluded[32]. Our data reveal that under conditions of compromised oligodendrocyte lipid synthesis, the extracellular lipids are supplied by astrocytes. Furthermore, our
data reveal that full myelin membrane synthesis requires an astrocyte lipid supply in addition
to endogenous oligodendrocyte lipid synthesis. Moreover, when astroglial lipid synthesis was
selectively compromised, oligodendrocytes incorporated circulating lipids into the myelin
membrane, and a lipid-enriched diet rescued hypomyelination, showing lipid flux from the
circulation to the myelin membrane under astrocyte metabolism-compromised conditions.

Involvement of astrocyte lipid metabolism in myelin membrane synthesis
We previously reported that GFAP-SCAP mutant mice have microcephaly without changes in
neuronal and astrocyte density[11]. Here, we show by structural MRI and DTI that volume
reduction was mostly pronounced in the white matter. Cells of the oligodendrocyte lineage
were not reduced in density; instead, the formation of fully developed myelin membranes was
lower in the GFAP-SCAP mutant, resulting in a functional loss of fast conduction myelinated
fibers. We conclude that GFAP-SCAP mutant mice have white matter atrophy that is caused
by persistent hypomyelination.
Although GFAP-SCAP mice showed clear CNS hypomyelination in adults (P120), hypomyelination was less pronounced in younger mutant animals. This suggests that depletion of
astrocyte lipids becomes most limiting after the first phase of myelination. Indeed, astrocytespecific deletion of SCAP, using Glast-CreERT2-tdT-SCAP mice, late in this developmental
phase of myelination prevents the establishment of a full myelin membrane in adults. In line
with this observation, oligodendrocytes produce large amounts of cholesterol during the peak
of myelination, but, thereafter, cholesterol synthesis occurs mainly in astrocytes[33,34]. It
should be noted that the myelin membrane surface increases exponentially with increasing
fiber diameter, during both myelin membrane wrapping and developmental axonal radial
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growth[35], which may underlie the elevated need for astrocyte lipids at a later stage of myelination. A role for astrocytes in the later stages of myelination is not unprecedented, as it was
previously reported that astrocytes support myelin membrane synthesis in vitro, as opposed to
OPC differentiation or initial myelin membrane wrapping[19]. Interestingly, astrocytes are in
contact with axons at the node and promote myelination in response to electrical impulses
[36]. This finding indicates a role for astrocytes in activity-dependent myelination, a process
that may underlie myelin plasticity relevant to learning in adults [3,36]. Whether the supply of
lipids from astrocytes to oligodendrocytes is regulated by axonal activity and is involved in
activity-dependent myelination in adults remains to be determined.
Our observation that hypomyelination in GFAP-SCAP mutants is more pronounced for
small-diameter axons might be related to the finding that large axons are the first to be myelinated during development [37]. Therefore, under conditions in which lipid supply is limited, e.g.,
when astrocyte-derived lipid supply is compromised, oligodendrocytes that enwrap large axons
are in favor to use the small amount of lipids initially available. The virtual absence of myelin
around each axon when SCAP is deleted in both oligodendrocytes and astrocytes shows that
these 2 cell types are the main lipid contributors for the oligodendrocyte myelin membrane.

Implications for understanding and dietary treatment of white matter
diseases
We propose that endogenous lipid levels in oligodendrocytes are sufficient for initial myelin
membrane synthesis in the first postnatal weeks, while subsequent elaboration of a full myelin
membrane requires lipid supply from astrocytes. Importantly, feeding astrocyte-lipid mutants
with a cholesterol- and oleic acid-enriched diet led to an increase in myelination; in particular,
small-diameter axons did benefit from this treatment. This indicates that lipids, with elevated
circulation levels, can reach the brain and are incorporated in the growing myelin membrane,
as we found for dietary sterols and essential fatty acids. The inability of a lipid-enriched diet to
improve myelination in CNP-SCAP/GFAP-SCAP mice may be related to the severity of the
developmental defect or their life span being too short for the diet to be effective. The exact
mechanisms by which this diet improved myelination in GFAP-SCAP mice remains to be
determined but may involve the close vicinity of astrocytes end-feet to blood capillaries and
thereby the uptake of circulating lipids by astrocytes and subsequent delivery of lipids to oligodendrocytes. It should be noted that although horizontal cholesterol transfer was suggested to
improve myelination in CNP-SQS mutant mice, a cholesterol-enriched diet did not improve
myelination in these mice [7], probably because oligodendrocytes do not have the same access
to circulating lipids as astrocytes. As such, we observed that dietary sterols (phytosterols) were
incorporated in GFAP-SCAP mutant myelin but not in CNP-SCAP mutant myelin. Our
results indicate that the extent of exogenous lipid uptake by oligodendrocytes for myelin membrane synthesis has been underestimated. Without astrocyte lipid synthesis, oligodendrocytes
are unable to finalize CNS myelination, leading to hypomyelinated and slower-conducting
fibers in adulthood. These data may have important implications in the understanding and
treatment of myelin diseases. Some of the myelin defective phenotypes are known to benefit
from dietary supplemented lipids, (SLOS, X-linked Adrenoleukodystrophy), however, with
mixed effects in different patients, which calls for optimization and detailed understanding of
the underlying mechanisms[38,39]. Considering the need of lipids for myelination and remyelination, our findings show that oligodendrocytes depend on astrocyte lipid metabolism, or on
lipids supplemented in the diet under astrocyte metabolism-compromised conditions, which
might be instrumental for the development of novel strategies aimed at restoring loss of function in myelin diseases.
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Methods
Mice
All experimental procedures were approved by the local animal research committee (Dierexperimentencommissie VU University, protocols: MCN10-04, MCN10-20, MCN12-16,
MCN13-01; MCN14-16) and complied with the European Council Directive (86/609/EEC).
All animals were housed and bred according to the institutional and Dutch governmental
guidelines for animal welfare. Extra care was taken of animals that suffered from genotypic
phenotypes and experimental procedures, including the use of humane endpoints.
SCAP-floxed mice were from the Jackson Laboratory and have been described[22]. The
hGFAP-Cre-IRES-LacZ transgenic mice, referred to as GFAP-Cre, predominantly targets Cremediated recombination in astrocytes[40] and only minor populations of neurons in the hippocampus[41], cortex[41], and cerebellum[42]. CNP-cre mice have been described [25]. GlastCreERT2 mice [29] and Rosa26-tdTomato mice [43] have been described and maintained by
breeding with SCAP loxP mice as Glast-creERT2-tdTomato-SCAP mice. Throughout the text,
mice of the GFAP-cre/SCAPloxP/loxP genotype were referred to as “GFAP-SCAP” mice, mice
of the CNP-cre/SCAPloxP/loxP genotype as “CNP-SCAP” mice, and mice of the CNP-cre/
GFAP-cre/SCAPloxP/loxP genotype as “CNP-SCAP/GFAP-SCAP” mice. CNP-SCAP/GFAPSCAP mice were obtained by breeding of GFAP-Cre(tg/0)//CNP-Cre(tg/0)//SCAPf/+ mice
with GFAP-Cre(0/0)//CNP-Cre0/0)//SCAPf/f mice. Littermates of CNP-SCAP/GFAP-SCAP
mice that were not homozygous for either CNP-SCAP, GFAP-SCAP, or both were taken as
controls. Mouse lines were maintained on a C57Bl6 background. Unless indicated otherwise,
food (Harlan Teklad, Madison, WI, USA) and water were provided ad libitum.

Tamoxifen treatment
Tamoxifen (Sigma-Aldrich) was dissolved in corn oil to a final concentration of 10 mg/ml.
Pups received a total amount of 10 μl per gram body weight through intraperitoneal injections
for 3 consecutive days at P15–P17.

Diets
Pregnant mice, on day 14 of gestation, were randomly separated in 2 groups. Group 1 received
the standard diet (Teklad diets, Harlan Laboratories, Madison, WI, USA), group 2 received
a high-fat diet containing 60% fat calories (1% cholesterol, 31% lard and 3% soybean oil,
TD.09167, Teklad diets). Fatty acid content of the diets has been described[11]. Pregnant mice
received the diets from the last week of gestation until weaning (3 weeks after birth). Animals
were separated at weaning, housed by gender, and continued to receive the same diet.

MRI and DTI
One-year-old WTs (n = 4) and GFAP-SCAP mutant mice (n = 5), were perfused transcardially
under deep anesthesia with 20 ml of PBS 0.1 M, pH 7.4 containing 0.1% heparin followed by
100 mL of freshly prepared cold fixative solution composed of 4% paraformaldehyde in 0.1 M
PBS, pH 7.4 [11]. Brains were removed, postfixed overnight in fixative solution at 4˚C, and
cryoprotected with 30% sucrose for 2–3 days at 4˚C [11]. Post mortem brains were fixated in a
syringe filled with perfluoro polyether (Fomblin, Solvay Solexis) to prevent magnetic susceptibility artifacts at the borders of the brain. High resolution DTI was performed to assess white
matter status, using a diffusion-weighted eight-shot spin-echo EPI sequence (TR/TE = 2700/
28 ms; field-of-view 20×20 mm; 156×156 μm voxels; 91×150 μm coronal slices; b = 2035.5 s/
mm2, δ = 5 ms, Δ = 13 ms; 2 sets of 60 diffusion-weighted images in noncollinear directions,
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and 4 unweighted images [b = 0]). The diffusion tensor for each voxel was calculated based on
the eigenvectors and eigenvalues using multivariate fitting and diagonalization. Derived fractional anisotropy (FA) maps were further analyzed basically as previously described[44] using
unbiased whole-brain tract-based spatial statistics[45]. Image-based registration was performed with Elastix[46]. FA maps of all animals were first aligned to a common reference
image using nonlinear registration of the average diffusion-weighted image with limited
degrees of freedom preceded by affine-only registration. The transformations that were
obtained from the nonlinear registration describe the local tissue volume changes that are
needed to match the images to the common reference. At the voxel level, volume expansion or
compression was quantified by the determinant of a transformation’s Jacobian matrix. Local
tissue volumes were then tested in a voxel-wise deformation-based morphometry analysis[47].
By thresholding the mean FA maps at 0.2, a skeleton of white matter tracts was obtained
shared across subjects. With a perpendicular search algorithm, subject FA maps were registered, starting from the skeleton towards individual tracts, and subsequently stacked into a
sparse skeletonized 4D image. Permutation tests with threshold-free cluster enhancement [45]
were conducted for each point at the mean FA skeleton to assess statistically significant differences between mutant and control groups.

Conduction velocity
Mice were decapitated, and the brains were rapidly removed and immersed in ice-cold artificial
cerebrospinal fluid (ACSF; containing NaCl 129 mM, KCl 3 mM, MgSO4 1.8 mM, CaCl2 1.6
mM, glucose 10 mM, NaH2PO4 1.25 mM, NaHCO3 21 mM; pH 7.4) carboxygenated with 5%
CO2 and 95% O2. Coronal slices (400 μm) were acutely prepared from the frontal cortex, including corpus callosum and hippocampus. After sectioning, slices were maintained at 21˚C and
recorded at room temperature (20˚C–22˚C) in a similar solution. Extracellular field currents
were recorded with Heka EPC-8 amplifiers (D-67466 Lambrechtt/Pfalz, Germany). The ACSFfilled glass microelectrodes were voltage clamped at 0 mV. The measurements were taken from
three different locations along the corpus callosum with platinum/iridium electrodes (FHC,
Bowdoin, ME 04287, USA). Data were low-pass filtered at 5 kHz, digitized at 20 kHz, with an
instrutech ITC-16 and pulse software (D-67466 Lambrecht/Pfalz, Germany) and analyzed offline with Igor Pro (Wavemetrics, 10200 SW Nimbus, G-7, Portland, USA). Evoked action currents were measured using 2 different recording electrodes and were both abolished by tetrodotoxine (TTX), a selective blocker of voltage-gated sodium channels (S4 Fig).

Lipid analysis
Myelin was purified by density gradient centrifugation [48], and lipids were isolated by lipid
extraction, as described previously [6]. Analysis of neutral lipids was done using a Sciex 4000
Q-trap mass spectrometer (AB Sciex, Framingham, MA, USA), equipped with an atmospheric
pressure chemical ionization source. Analysis of free fatty acids was done after mild alkaline
hydrolysis of isolated phospholipid fractions from lipid extracts, as described previously[5,6].
Analysis of intact phospholipids were analyzed using defined molecular species and authentic
free fatty acid standards, as described previously[5,6].

Statistical analysis
Statistical differences were analyzed using Student’s t test, unless otherwise indicated in
the legends. Statistical numeric data are provided in the legends. Data are presented as
mean ± SEM.
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Additional methods
Description of additional methods, including EM, morphometric analysis, immunoblotting,
and immunohistochemistry are available in S1 Text.

Supporting information
S1 Fig. A) Expression of fatty acid synthase (FASN, green) in WT mice at P21. CC: Corpus
Callosum; CA: Cornu Ammonis; DG: Dentate Gyrus (scale bar, 250 μm). B) Expression of
FASN (green) is not localized in neurons (NeuN, red) in the cortex (scale bar, 25 μm). C)
Expression of FASN (green) is not localized in neurons (NeuN, red) in the CA1 region of the
hippocampus (scale bar, 25 μm).
(TIF)
S2 Fig. A) Data from 3D MRI brain scans of 1-year old GFAP-SCAP and WT mice. Deformation-based morphometry analysis revealed regional differences in tissue volumes in the brains of
GFAP-SCAP in the cerebullum, thalamus, and anterior corpus callosum. Significant localized
higher volumes in WT (n = 4) as compared to GFAP-SCAP (n = 5) are shown as red to yellow
voxels (p < 0.05 to 0.0001). Significant lower volumes are shown in blue to light blue voxels
(p < 0.05 to 0.0001). The statistical maps are overlaid on the coronal slices of the average
T2-weighted wild-type image (from posterior to anterior). B) Voxel-based analysis of fractional
anisotropy map is shown in green. Statistical comparison was restricted to a white matter skeleton
(white; fractional anisotropy > 0.2) using tract-based spatial statistics. Significant lower fractional
anisotropy voxels in the GFAP-SCAP mice as compared to WT mice are shown in blue (p < 0.05;
false discovery rate-corrected). These voxels are in particular located in the corpus callosum.
(TIF)
S3 Fig. Effect of HFD on myelin membrane synthesis in CNP-SCAP/GFAP-SCAP brains.
EM analysis of A) corpus callosum (CC) and B) optic nerve (ON) in P20 WT mice or mice carrying a deletion in both astrocytes and oligodendrocytes (CNP-SCAP/GFAP-SCAP), on standard diet (SD) or high fat diet (HFD). Scale bar, 2 μm.
(TIF)
S4 Fig. Experimental design of conduction velocity experiments. A) Shown is the position
of the action potential evoking electrode (labelled with "Stim") and the 2 recording electrodes
("Rec 1," and "Rec 2"). B) Example of the recorded signal showing in blue the signal recorded
with electrode 1, and in orange the signal recorded with electrode 2. C) Inhibition of the signal
by 1 μm tetrodotoxin (TTX) applied in the bath before stimulation.
(TIF)
S1 Text. Description of additional methods, including electron microscopy and morphometric analysis, immunoblotting, and immunohistochemistry.
(DOCX)
S1 Data. Excel spreadsheet containing, in separate sheets, the underlying numerical data
for figure panels 1B, 1D, 1E, 1F, 2A, 2B, 2C, 3A, 3B, 3C, 4A, 4C, 5A, 5B, 5C, 5D, 6A, 6B,
7B, 7C, 7D, 7E, 7F, 8A, 8B, 8C, 9A, 9B, 9C, 10A, 10C.
(XLSX)
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